The global Protein A Resin Market, valued at USD 1.4 billion in 2022, is poised for significant growth, with projections indicating a market size of USD 2.97 billion by 2030. This growth is anticipated to occur at a robust compound annual growth rate (CAGR) of 9.9% during the forecast period from 2023 to 2030.

Protein A resin is a key component in the purification of monoclonal antibodies (mAbs), playing a critical role in downstream processing in the biopharmaceutical industry. With the increasing demand for biologics and monoclonal antibodies for the treatment of various diseases, the Protein A Resin Market is witnessing substantial growth.

Get Sample PDF @ https://www.snsinsider.com/sample-request/3364 

Key Players

The major key players are Danaher Corporation, Merck KGAa, Repligen Corporation, Thermo Fisher Scientific, Agilent Technologies, GenScript, PerkinEimer Inc., Bio-Rad Laboratories, Inc., Orochem Technologies Inc., Kaneka Corporation, Abcam Plc., Agarose Bead Technologies, Avantor, Inc., and others.

Key factors driving the growth of the Protein A Resin Market include:

  1. Rising Demand for Monoclonal Antibodies (mAbs): The growing prevalence of chronic and autoimmune diseases, coupled with the expanding applications of monoclonal antibodies in therapeutic interventions, is driving the demand for Protein A resin in the biopharmaceutical industry.

  2. Advancements in Bioprocessing Technologies: Ongoing advancements in bioprocessing technologies, including improvements in Protein A resin chemistry, column design, and process optimization, are enhancing the efficiency and scalability of mAb purification processes.

  3. Increasing Investments in Biopharmaceutical R&D: Pharmaceutical companies and biotechnology firms are ramping up their investments in research and development of biologics, leading to a greater demand for Protein A resin for downstream purification processes.

  4. Growing Adoption of Biosimilars: The increasing adoption of biosimilars as cost-effective alternatives to branded biologics is driving the demand for Protein A resin, as biosimilars also require purification processes similar to those used for originator biologics.

KEY SEGMENTS

By Product

  • Agarose based protein A resin

  • Glass/Silica based protein A resin

  • Organic Polymer based protein A resin

By Type

  • Recombinant protein A resin

  • Natural protein A resin

By Application

  • Antibody Purification

  • Immunoprecipitation

By End User

  • Pharmaceutical and biopharmaceutical companies

  • Academic Research institutes

  • Other end users

The forecast period of 2023-2030 is expected to witness continued innovation in Protein A resin technology, with a focus on improving resin capacity, selectivity, and cost-effectiveness to meet the evolving needs of the biopharmaceutical industry.

Geographically, North America currently dominates the Protein A Resin Market, driven by the presence of a well-established biopharmaceutical sector, high adoption rates of biologics, and significant investments in research and development. However, regions such as Europe, Asia Pacific, and Latin America are expected to witness substantial growth during the forecast period, fueled by expanding biopharmaceutical manufacturing capabilities and increasing demand for mAbs.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.snsinsider.com